Clinical Trials Logo
  1. Home
  2. Diabetes Mellitus, Type 2
  3. NCT03021746
  4. Details
NCT03021746 Clinical Trial

Fostering Sustainability Through Diabetes Self-Management Support

Diabetes Mellitus Clinical Trial

Official title:
Fostering Sustainability Through Diabetes Self-Management Support

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03021746
Other study ID # HUM00104965
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2016
Est. completion date August 31, 2021

Study information
Verified date December 2021
Source University of Michigan
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To understand the effectiveness of three approaches to address diabetes self-management support compared to enhanced usual care in church-based settings.

Description:

To understand the effectiveness of three approaches to address diabetes self-management support compared to enhanced usual care in church-based settings.

Recruitment information / eligibility
Status Completed
Enrollment 358
Est. completion date August 31, 2021
Est. primary completion date August 31, 2021
Accepts healthy volunteers No
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: - Have Type 2 diabetes for at least 6 months - Be Black/African American - Be a resident of metro-Detroit, Toledo, or Flint - Be at least 21 years old - Be under the care of a physician for diabetes - Have transportation to attend the program Exclusion Criteria: - Have Type 2 diabetes for less than 6 months - Under 21 years of age - Not under care of physician - Lack of transportation to attend the program

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• Diabetes Self Management Support (DSMS)

Locations
Country Name City State
United States University of Michigan Ann Arbor Michigan

Sponsors (2)
Lead Sponsor Collaborator
University of Michigan National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Change in A1C Blood Glucose level An A1C test is a blood test that reflects one's average blood glucose levels over the previous 3 months. During this study, A1c will be measured at five time points; baseline, 6 months, 9 months, 21 months, and 33 months.
See also
  Status Clinical Trial Phase
Completed NCT03743779 - Mastering Diabetes Pilot Study
Completed NCT03786978 - Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus N/A
Completed NCT01804803 - DIgital Assisted MONitoring for DiabeteS - I N/A
Completed NCT05039970 - A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04068272 - Safety of Bosentan in Type II Diabetic Patients Phase 1
Completed NCT03243383 - Readmission Prevention Pilot Trial in Diabetes Patients N/A
Completed NCT03730480 - User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS) N/A
Recruiting NCT02690467 - Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm. N/A
Completed NCT02229383 - Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus Phase 3
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Completed NCT06181721 - Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes N/A
Recruiting NCT04489043 - Exercise, Prediabetes and Diabetes After Renal Transplantation. N/A
Withdrawn NCT03319784 - Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients Phase 4
Completed NCT03542084 - Endocrinology Auto-Triggered e-Consults N/A
Completed NCT02229396 - Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo Phase 3
Recruiting NCT05544266 - Rare and Atypical Diabetes Network
Completed NCT01892319 - An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Completed NCT05031000 - Blood Glucose Monitoring Systems: Discounter Versus Brand N/A
Recruiting NCT04039763 - RT-CGM in Young Adults at Risk of DKA N/A